Much has been learned in the past decade about the intracellular mechanisms involved in the presentation of peptides by MHC class I molecules. Most MHC class I associated peptides are derived from proteasome-mediated degradation of cytosolic proteins [3] . Proteasomes are complex, multisubunit proteases that generate peptides of an appropriate length for association with MHC class I molecules. Cytosolic peptides are transported via an ATPdependent process into the endoplasmic reticulum by the transporter associated with antigen processing (TAP), a heterodimeric transporter protein. Newly synthesized, 'empty' MHC class I molecules associate with TAP and bind the peptides transported by this protein [1] . Upon peptide binding, MHC class I molecules dissociate from TAP, traverse the Golgi complex and move to the cell surface. The majority of MHC class I antigen processing is dependent upon proteasome and TAP function.
Even before there was any clear understanding of the antigen-processing pathways, investigations by Bevan [4] demonstrated that antigen presentation in vivo need not follow the conventional pathway. These early studies demonstrated that T cells could respond to peptides derived from cells that did not express the restricting MHC molecule. This process was called cross-priming, because it was correctly assumed that antigen was being transferred from the immunizing cells, which lacked the restricting MHC class I molecule, to host cells which did express the restricting MHC class I molecule. This and subsequent work pointed towards the existence of cells that could present antigen by taking up exogenous cellular material and feeding it into the MHC class I antigen-processing pathway. Indeed, studies of tumor-specific immunity have demonstrated that cross-priming plays a major role in the generation of CTLs that recognize tumor-specific antigens [5] . Recent studies suggest that cross-priming may be the major pathway for CTL priming [6] . Interestingly, crosspriming appears to be highly dependent on the interaction of both antigen-specific CD4 + and CD8 + T lymphocytes with the same individual antigen-presenting cell (APC). Although exogenous soluble antigens do not access the MHC class I antigen-processing pathway, CTLs efficiently recognize peptide-MHC complexes on macrophages that have phagocytosed antigen-coated particles [7] . Interestingly, this particulate MHC class I antigen-presentation pathway and the in vivo cross-priming process are both TAP dependent, indicating that exogenous antigens are entering the cytosol of the APC [5, 7] .
A number of bacterial pathogens escape antibody-mediated immune defenses by entering cells. One such pathogen is the Gram-positive bacterium Listeria monocytogenes, which is phagocytosed by macrophages and enters the cytosol by secreting the protein listeriolysin, which lyses cell membranes. Some of the proteins that L. monocytogenes secretes into the host cell cytosol are degraded by proteasomes into peptides that then become bound by MHC class I molecules. Infection with L. monocytogenes elicits a robust CTL response in mice that is specific for many different secreted proteins and peptides [8] . Entry of L. monocytogenes into the cytosol is essential for the presentation of antigens to CTL [9] . Indeed, immunization with bacteria that lack listeriolysin does not result in protective immunity [10] . Remarkably, all of the MHC class I restricted L. monocytogenes epitopes that have been identified so far are either secreted peptides or derive from secreted proteins [8] . Although secreted proteins account for only 1-2% of total bacterial protein synthesis [11] , they are the target of more than 70% of the MHC class I restricted CTL response to L. monocytogenes infection [12] . These findings suggest that secreted proteins have a selective advantage when it comes to priming CTLs during bacterial infection.
The first study to directly address the role of antigen secretion in the generation of protective immunity was performed by Hess, Kaufmann and colleagues [13] . They expressed two L. monocytogenes antigens, listeriolysin and p60, in Salmonella typhimurium as secreted or non-secreted forms. Mice immunized with S. typhimurium expressing the secreted forms of these antigens were protected against future L. monocytogenes infection, whereas immunization with S. typhimurium expressing the non-secreted antigens did not induce protective immunity. Interestingly, the protective immunity that resulted from immunization with recombinant S. typhimurium involved both CD4 + and CD8 + T lymphocytes. This finding is remarkable, because S. typhimurium remains confined to an intracellular vacuole and is unable to directly access the MHC class I antigen-processing pathway.
The two antigens that were used in this study, p60 and listeriolysin, are both secreted by L. monocytogenes. To determine whether secreted antigens are exclusively the targets of protective immunity, Hess and colleagues next engineered a secretable version of the non-secreted L. monocytogenes protein superoxide dismutase (SOD), expressed this protein in S. typhimurium and immunized mice with this recombinant bacterium [14] . Surprisingly, mice were protected from L. monocytogenes infection, again by both CD4 + and CD8 + T lymphocytes. Thus, although antigen secretion by S. typhimurium is critical for the induction of protective immunity, antigen secretion by the target of the protective immune response, in this case L. monocytogenes, appears not to be essential.
The role of protein secretion in antigenicity was further dissected by Shen and colleagues [15] , who performed a careful analysis of the CTL response to a lymphocytic choriomeningitis virus (LCMV) epitope (NP 118-126, amino acids 118-126 of the LCMV nucleoprotein) contained within an engineered protein that was either secreted by L. monocytogenes or retained within the bacterium. Care was taken to generate L. monocytogenes strains that either secreted or retained similar amounts of the antigen. An important consequence of this manipulation, however, is that antigen-retaining bacteria carry significantly more antigen into host cells than antigen-secreting bacteria. Nevertheless, mice were infected with these two strains of bacteria and T-cell responses to NP 118-126 were quantified. Surprisingly, the magnitude of the T-cell response to the LCMV epitope was similar in mice immunized with either antigen-secreting or antigen-retaining strains of L. monocytogenes. Importantly, mice immunized with either strain had equivalent immunity to LCMV infection, demonstrating that protective immunity could be induced with a non-secreted antigen.
Although this result appears to contradict the findings with non-secreted S. typhimurium antigens [13, 14] , there are some important differences between the two systems that typhimurium is confined to the membraneenclosed vacuole whereas L. monocytogenes enters the cytosol. The implications for T-cell responses and protective immunity to secreted and non-secreted forms of antigens (represented as coloured rectangles) carried by these bacteria, as determined by Hess and colleagues [13, 14] and Shen and colleagues [15] (Figure 1) . First, S. typhimurium resides in the vacuoles of the host cell whereas L. monocytogenes enters the cytosol of infected cells. Thus, different subcellular compartmentalization of the antigencarrying bacterium may account for the lack of priming with non-secreted S. typhimurium antigens and efficient priming with non-secreted L. monocytogenes antigens. Second, S. typhimurium predominantly infects macrophages whereas L. monocytogenes infects macrophages, hepatocytes and perhaps other cells. Thus, priming of CTLs for non-secreted bacterial antigens may require infection of cells that are not 'professional' APCs. Third, although both of these bacteria are intracellular pathogens, they differ quite dramatically from each other. L. monocytogenes is a Gram-positive bacterium that induces high levels of interleukin-12 production from macrophages [16] , whereas S. typhimurium is a Gram-negative bacterium that contains lipopolysaccharide and induces a distinct inflammatory response. It is possible, indeed likely, that the different inflammatory responses to these two different pathogens have distinct effects on the priming and expansion of T cells.
Shen and colleagues [15] also investigated the ability of CTLs specific for non-secreted antigens to protect against L. monocytogenes infection. Specifically, mice were immunized with LCMV, which primes a CTL response specific for NP 118-126. Immunized mice were then challenged with L. monocytogenes that either secreted or retained the engineered NP 118-126 antigen. Mice that were immune to LCMV resisted infection by antigensecreting bacteria, but not by bacteria that retained the antigen intrabacterially. This finding suggests that although non-secreted antigens can prime CTLs, these antigens are not adequately presented to CTLs during systemic L. monocytogenes infection to play a role in the clearance of bacteria in vivo.
These findings also appear to contradict those of Hess and colleagues [13, 14] , but again there are substantial differences between the two systems. For example, the immunizing and challenging antigens differ. In the case of SOD, this protein antigen expressed in the immunizing S. typhimurium was the same as that expressed in the challenging L. monocytogenes and contained both MHC class I restricted and MHC class II restricted epitopes [14] . In contrast, the immunizing LCMV and the challenging L. monocytogenes strain shared only the NP 118-126 epitope (and three flanking amino acids on each side), essentially limiting the similarity of the two antigens to a single MHC class I restricted epitope [15] . This difference, together with the involvement of both CD4 + and CD8 + T-cell responses to SOD and only CD8 + T-cell responses to NP 188-126 may account for the ability of SOD-specific T cells to protect against L. monocytogenes infection.
Is cross-priming involved in the CTL response to L. monocytogenes infection? More specifically, is the generation of a CTL response to a non-secreted L. monocytogenes protein best explained by cross-priming? These questions will require further work and additional experimental approaches before the answers become clear. Unlike studies with antigen-coated particles [7] , in the experiments described by Shen et al. [15] the antigen is contained within a Gram-positive bacterium, a rather dramatic difference. How is a Gram-positive bacterium, which is enclosed by a thick wall of peptidoglycan, cracked open and how are internal antigens extracted and processed by either the conventional or the cross-priming MHC class I antigen-processing pathways? The answers to these questions will be very revealing.
The relative role of secreted versus non-secreted proteins in protective immunity is of significant importance for vaccine development. The studies by Shen and colleagues [15] suggest that immunization resulting in a CTL response specific for a single epitope can be protective only if the epitope derives from a secreted antigen. Hess and Kaufmann's work [13, 14] , on the other hand, suggests that if immune responses are targeted against more complex antigens, even bacterially retained proteins can contribute to protective immunity. These contrasting studies provide a foundation for future work exploring the mechanisms of T-cell priming and should contribute to the rational design of vaccines.
